Iovance Biotherapeutics (IOVA) Stock Chart & Stock Price History → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free IOVA Stock Alerts $9.70 -0.31 (-3.10%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Iovance Biotherapeutics Stock Price Performance5 Day Performance-5.46%1 Month Performance-16.67%3 Month Performance-44.35%6 Month Performance+74.15%Year-To-Date Performance+19.31%1 Year Performance+28.48% Receive IOVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. IOVA Stock Chart for Tuesday, May, 28, 2024 IOVA Chart by TradingView Iovance Biotherapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$10.01$9.70-3.10%$10.26$9.684.40 million shs$2.71 billion05/27/2024$10.01$10.01$10.88$9.856.52 million shs$2.80 billion05/24/2024$10.26$10.01-2.44%$10.88$9.856.51 million shs$2.80 billion05/23/2024$10.33$10.26-0.68%$10.38$9.925.65 million shs$2.89 billion05/22/2024$10.32$10.33+0.10%$10.54$10.105.27 million shs$2.89 billion05/21/2024$10.35$10.32-0.29%$10.84$10.154.63 million shs$2.89 billion Get the Latest News and Ratings for IOVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$10.24$10.35+1.07%$10.45$10.083.93 million shs$2.90 billion05/17/2024$10.43$10.24-1.82%$10.59$10.184.49 million shs$2.87 billion05/16/2024$10.68$10.43-2.34%$10.80$10.314.70 million shs$2.92 billion05/15/2024$10.72$10.68-0.37%$11.39$10.647.03 million shs$2.99 billion05/14/2024$10.88$10.72-1.47%$11.17$10.646.56 million shs$3.00 billion05/13/2024$10.97$10.88-0.78%$11.47$10.439.97 million shs$3.04 billion05/10/2024$13.45$10.97-18.48%$13.20$10.7019.12 million shs$3.07 billion05/09/2024$13.39$13.45+0.45%$13.59$13.044.69 million shs$3.76 billion05/08/2024$13.98$13.39-4.22%$13.88$13.114.20 million shs$3.75 billion05/07/2024$13.88$13.98+0.72%$14.13$13.533.95 million shs$3.91 billion05/06/2024$13.63$13.88+1.83%$14.23$13.734.86 million shs$3.88 billion05/03/2024$12.88$13.63+5.82%$13.88$13.304.29 million shs$3.81 billion05/02/2024$12.50$12.88+3.04%$12.90$12.314.09 million shs$3.60 billion05/01/2024$11.78$12.50+6.11%$13.00$11.755.76 million shs$3.49 billion04/30/2024$12.03$11.78-2.08%$12.49$11.704.42 million shs$3.29 billion04/29/2024$11.64$12.03+3.35%$12.11$11.724.56 million shs$3.36 billion04/26/2024$11.54$11.64+0.87%$11.80$11.342.49 million shs$3.25 billion04/25/2024$11.71$11.54-1.45%$11.65$11.163.40 million shs$3.22 billion04/24/2024$11.86$11.71-1.26%$12.13$11.682.93 million shs$3.27 billion04/23/2024$11.32$11.86+4.77%$11.97$11.413.87 million shs$3.31 billion04/22/2024$11.31$11.32+0.09%$11.64$11.072.40 million shs$3.16 billion04/19/2024$11.72$11.31-3.50%$11.69$11.015.26 million shs$3.16 billion04/18/2024$11.80$11.72-0.68%$11.91$11.483.70 million shs$3.27 billion04/17/2024$11.92$11.80-1.01%$12.12$11.653.14 million shs$3.30 billion04/16/2024$11.89$11.92+0.25%$12.14$11.535.40 million shs$3.33 billion04/15/2024$12.36$11.89-3.80%$12.53$11.666.39 million shs$3.32 billion04/12/2024$13.19$12.36-6.29%$13.13$12.174.50 million shs$3.45 billion04/11/2024$12.58$13.19+4.85%$13.22$12.493.75 million shs$3.68 billion04/10/2024$13.22$12.58-4.84%$12.73$12.115.65 million shs$3.51 billion04/09/2024$13.07$13.22+1.15%$13.30$12.914.23 million shs$3.69 billion04/08/2024$13.53$13.07-3.40%$13.59$12.894.66 million shs$3.65 billion04/05/2024$13.60$13.53-0.51%$13.89$13.203.38 million shs$3.78 billion04/04/2024$14.01$13.60-2.93%$14.21$13.404.09 million shs$3.80 billion04/03/2024$13.77$14.01+1.74%$14.20$13.274.55 million shs$3.91 billionMissed NVDA? Buy this AI stock NOW (Ad)After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here.04/02/2024$14.19$13.77-2.96%$14.16$13.565.51 million shs$3.85 billion04/01/2024$14.82$14.19-4.25%$14.75$13.994.01 million shs$3.96 billion03/29/2024$14.82$14.82$15.18$14.106.19 million shs$4.14 billion03/28/2024$14.10$14.82+5.11%$15.18$14.106.19 million shs$4.14 billion03/27/2024$14.05$14.10+0.36%$14.32$13.754.11 million shs$3.94 billion03/26/2024$14.53$14.05-3.30%$15.04$13.955.10 million shs$3.92 billion03/25/2024$15.02$14.53-3.26%$15.50$14.444.57 million shs$4.06 billion03/22/2024$15.36$15.02-2.21%$15.44$14.863.69 million shs$4.20 billion03/21/2024$14.93$15.36+2.88%$15.90$15.027.29 million shs$4.29 billion03/20/2024$13.90$14.93+7.41%$15.01$13.705.86 million shs$4.17 billion03/19/2024$14.03$13.90-0.93%$14.26$13.605.23 million shs$3.88 billion03/18/2024$13.91$14.03+0.86%$14.65$13.606.69 million shs$3.92 billion03/15/2024$14.21$13.91-2.11%$14.39$13.6818.15 million shs$3.89 billion03/14/2024$14.73$14.21-3.53%$14.82$13.937.04 million shs$3.97 billion03/13/2024$14.72$14.73+0.07%$15.01$14.356.39 million shs$4.11 billion03/12/2024$15.10$14.72-2.52%$15.29$14.607.21 million shs$4.11 billion03/11/2024$15.70$15.10-3.82%$15.99$14.807.94 million shs$4.22 billion03/08/2024$16.62$15.70-5.54%$17.14$15.1111.45 million shs$4.39 billion03/07/2024$17.16$16.62-3.15%$17.55$16.526.31 million shs$4.64 billion03/06/2024$16.49$17.16+4.06%$17.64$16.698.23 million shs$4.79 billion03/05/2024$16.96$16.49-2.77%$17.28$15.978.66 million shs$4.61 billion03/04/2024$16.79$16.96+1.01%$18.22$16.6212.32 million shs$4.74 billion03/01/2024$15.91$16.79+5.53%$17.19$16.2711.00 million shs$4.30 billion02/29/2024$17.43$15.91-8.72%$17.41$15.5017.50 million shs$4.07 billion02/28/2024$17.47$17.43-0.23%$18.33$16.9511.79 million shs$4.46 billion02/27/2024$16.60$17.47+5.24%$17.60$16.1511.46 million shs$4.47 billion Related Companies: Apogee Therapeutics Stock Chart Arcellx Stock Chart Denali Therapeutics Stock Chart SpringWorks Therapeutics Stock Chart Twist Bioscience Stock Chart Immunocore Stock Chart Vericel Stock Chart Recursion Pharmaceuticals Stock Chart ADMA Biologics Stock Chart Kymera Therapeutics Stock Chart Receive IOVA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IOVA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.